ZyVersa Therapeutics Inc [NASDAQ: ZVSA] price surged by 15.45 percent to reach at $0.09.
The one-year ZVSA stock forecast points to a potential upside of 96.7. The average equity rating for ZVSA stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on ZyVersa Therapeutics Inc [ZVSA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZVSA shares is $20.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZVSA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for ZyVersa Therapeutics Inc is set at 0.09 The Price to Book ratio for the last quarter was 0.21, with the Price to Cash per share for the same quarter was set at 0.34.
ZVSA Stock Performance Analysis:
ZyVersa Therapeutics Inc [ZVSA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.80. With this latest performance, ZVSA shares dropped by -1.72% in over the last four-week period, additionally sinking by -41.69% over the last 6 months – not to mention a drop of -84.71% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZVSA stock in for the last two-week period is set at 55.77, with the RSI for the last a single of trading hit 66.01, and the three-weeks RSI is set at 50.79 for ZyVersa Therapeutics Inc [ZVSA]. The present Moving Average for the last 50 days of trading for this stock 0.6590, while it was recorded at 0.5787 for the last single week of trading, and 1.4406 for the last 200 days.
Insight into ZyVersa Therapeutics Inc Fundamentals:
ZyVersa Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.18 and a Current Ratio set at 0.18.
